Drug-Induced Liver Injury: Biomarkers, Requirements, Candidates, and Validation

by Lucy Meunier, Dominique Larrey
Published 2019-12-01

Recent Advances in Hepatotoxicity of Non Steroidal Anti-inflammatory Drugs

by Lucy Meunier, Dominique Larrey
Published 2018-03-01

Chemotherapy-associated steatohepatitis

by Lucy Meunier, Dominique Larrey
Published 2020-11-01

Liver Biopsy in Chronic Liver Diseases: Is There a Favorable Benefit: Risk Balance?

by Dominique Larrey, Lucy Meunier, José Ursic-Bedoya
Published 2017-07-01

Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such as MicroRNAs

by Rolf Teschke, Dominique Larrey, Dieter Melchart, Gaby Danan
Published 2016-07-01

Hepatitis C virus infection impacts work productivity and fatigue: An epidemiologic real-life study

by Victor de Ledinghen, Bertrand Hanslik, Joseph Moussalli, Si Nafa Si Ahmed, Denis Ouzan, Dominique Larrey
Published 2019-09-01

Quality of life in patients with chronic hepatitis C infection: Severe comorbidities and disease perception matter more than liver-disease stage.

by Sabrina Cossais, Michaël Schwarzinger, Stanislas Pol, Hélène Fontaine, Dominique Larrey, Georges-Philippe Pageaux, Valérie Canva, Philippe Mathurin, Yazdan Yazdanpanah, Sylvie Deuffic-Burban
Published 2019-01-01

Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trial.

by Diego García-Compean, MD, Pierre Blanc, MD, Dominique Larrey, MD, Jean-Pierre Daures, MD, Jacques Hirtz, MD, Eduardo Mendoza, MD, Héctor Maldonado, MD, Henri Michel, MD
Published 2002-01-01

A Proof of Concept, Phase II Randomized European Trial, on the Efficacy of ALF-5755, a Novel Extracellular Matrix-Targeted Antioxidant in Patients with Acute Liver Diseases.

by Bertrand Nalpas, Philippe Ichaï, Laure Jamot, Nicolas Carbonell, Marika Rudler, Philippe Mathurin, François Durand, Guido Gerken, Michael Manns, Christian Trautwein, Dominique Larrey, Sylvie Radenne, Christophe Duvoux, Vincent Leroy, Jacques Bernuau, Jamila Faivre, Nicolas Moniaux, Christian Bréchot, Gilles Amouyal, Paul Amouyal, Didier Samuel
Published 2016-01-01

Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the...

by Frédégonde About, Tiphaine Oudot-Mellakh, Jonathan Niay, Pascaline Rabiéga, Vincent Pedergnana, Darragh Duffy, Philippe Sultanik, Carole Cagnot, Fabrice Carrat, Patrick Marcellin, Fabien Zoulim, Dominique Larrey, Christophe Hézode, Hélène Fontaine, Jean-Pierre Bronowicki, Stanislas Pol, Matthew L Albert, Ioannis Theodorou, Aurélie Cobat, Laurent Abel, ANRS CO20-CUPIC study group
Published 2015-01-01

Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort

by Anne Laurain, Sophie Metivier, Georges Haour, Dominique Larrey, Céline Dorival, Christophe Hezode, Fabien Zoulim, Patrick Marcellin, Marc Bourliere, Jean-Pierre Zarski, Dominique Thabut, Laurent Alric, Nathalie Ganne-Carrie, Paul Cales, Jean-Pierre Bronowicki, Ghassan Riachi, Claire Geist, Xavier Causse, Armand Abergel, Olivier Chazouilleres, Philippe Mathurin, Dominique Guyader, Didier Samuel, Albert Tran, Véronique Loustaud-Ratti, Ventzislava Petrov-Sanchez, Alpha Diallo, Clovis Luzivika-Nzinga, Hélène Fontaine, Fabrice Carrat, Stanislas Pol, on behalf of the ANRS/AFEF HEPATHER study group
Published 2019-04-01